Edition:
United States

Cellular Biomedicine Group Inc (CBMG.OQ)

CBMG.OQ on NASDAQ Stock Exchange Global Market

16.95USD
23 Feb 2018
Change (% chg)

$-0.10 (-0.59%)
Prev Close
$17.05
Open
$17.20
Day's High
$17.35
Day's Low
$16.80
Volume
2,168
Avg. Vol
12,812
52-wk High
$22.75
52-wk Low
$5.15

Chart for

About

Cellular Biomedicine Group Inc. is a United States-based company which is engaged in the development of cell therapy technologies. The Company develops proprietary cell therapies for the treatment of cancer and degenerative diseases. The Company conducts immuno-oncology and stem cell clinical trials in China using products from... (more)

Overall

Beta: 3.31
Market Cap(Mil.): $237.47
Shares Outstanding(Mil.): 14.01
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 195.87 16.59
EPS (TTM): -- -- --
ROI: -- -0.71 35.07
ROE: -- -3.37 17.79

BRIEF-Cellular Biomedicine Group Announces $30.6 Mln Investment From Sailing Capital Overseas Investment

* CELLULAR BIOMEDICINE GROUP ANNOUNCES $30.6 MILLION INVESTMENT FROM SAILING CAPITAL OVERSEAS INVESTMENT LTD.

Feb 05 2018

BRIEF-Cellular Biomedicine Group Says Enters Securities Purchase Agreement With Certain Investors

* CELLULAR BIOMEDICINE GROUP SAYS ON JAN 30, CO ENTERED INTO A SECURITIES PURCHASE AGREEMENT WITH CERTAIN INVESTORS - SEC FILING

Jan 31 2018

BRIEF-Cellular Biomedicine Announces Plan To Configure Part Of Shanghai Facility

* CELLULAR BIOMEDICINE GROUP INC - ANNOUNCED PLAN TO CONFIGURE PART OF ITS FACILITY IN SHANGHAI WITH GE HEALTHCARE'S FLEXFACTORY PLATFORM

Jan 18 2018

BRIEF-Cellular Biomedicine Group reports qtrly ‍loss per share $0.43

* Cellular Biomedicine Group reports third quarter financial results and recent operational highlights

Nov 09 2017

BRIEF-Thermo Fisher Scientific and Cellular Biomedicine announce partnership to develop manufacturing processes

* Thermo Fisher Scientific and Cellular Biomedicine Group announce strategic partnership to develop manufacturing processes

Nov 06 2017

BRIEF-BioLife Solutions CryoStor cell freeze media embedded in Cellular Biomedicine Group clinical trial of AlloJoin

* BioLife Solutions CryoStor cell freeze media embedded in Cellular Biomedicine Group clinical trial of AlloJoin Source text for Eikon: Further company coverage:

Sep 19 2017

Earnings vs. Estimates